KPIs & Operating Metrics(New)
Cash Flow Statement
Growth Metrics

Bausch Health Companies (BHC) Debt to Equity (2016 - 2026)

Bausch Health Companies' Debt to Equity history spans 18 years, with the latest figure at -$10.08 for Q1 2026.

  • On a quarterly basis, Debt to Equity rose 88.75% to -$10.08 in Q1 2026 year-over-year; TTM through Mar 2026 was -$10.08, a 88.75% increase, with the full-year FY2025 number at $55.22, up 426.72% from a year prior.
  • Debt to Equity hit -$10.08 in Q1 2026 for Bausch Health Companies, down from $55.22 in the prior quarter.
  • Over the last five years, Debt to Equity for BHC hit a ceiling of $147.88 in Q2 2025 and a floor of -$273.02 in Q4 2023.
  • Historically, Debt to Equity has averaged -$15.59 across 5 years, with a median of -$10.08 in 2026.
  • Biggest five-year swings in Debt to Equity: tumbled 441.84% in 2023 and later skyrocketed 426.72% in 2025.
  • Tracing BHC's Debt to Equity over 5 years: stood at $79.87 in 2022, then tumbled by 441.84% to -$273.02 in 2023, then soared by 93.81% to -$16.9 in 2024, then skyrocketed by 426.72% to $55.22 in 2025, then tumbled by 118.26% to -$10.08 in 2026.
  • Business Quant data shows Debt to Equity for BHC at -$10.08 in Q1 2026, $55.22 in Q4 2025, and $59.11 in Q3 2025.